TG and thyroid hormone resistance syndrome: The majority (around 85%) of patients with RTH have mutations in the thyroid hormone receptor β (TRß) gene, resulting in dysfunctional beta receptors, which have also been found to diminish the activity of normal receptors, explaining the unresponsiveness of end-organ tissues to thyroid hormone [14].